The Sputnik Light vaccine has confirmed its efficacy in an authoritative international journal, but it has
What has become known after the published results of a vaccine study?
The Lancet has an article on efficiencysingle-component vaccine "Sputnik Light". The study involved 110 volunteers 18–59 years old from St. Petersburg. First, they were tested for antibodies to a new type of coronavirus. 14 people had them, and 96 did not. According to this principle, two groups were formed.
One injection of the vaccine was enough to causeimmune response in volunteers assigned to the group without antibodies. As a result, 96 people (100%) developed specific antibodies in their blood serum as early as 42 days after the administration of Sputnik Light.
In volunteers who had antibodies in advance, an immune response was detected after 10 days.The authors of the study measured antibody levels on the 10th, 28th and 42nd days after the vaccine administration.In all three stages, the average antibody titers were higher in those volunteers who were already immune before the study.
This information confirms that sufficientmaintain antibodies and be revaccinated with a single dose of vaccine. Earlier it became known that after inoculation with the second component "Sputnik V", the amount of antibodies does not increase. A similar study was published for Pfizer.
Who is Sputnik Light suitable for?
According to the head of the Ministry of Health, Mikhail Murashko, the Sputnik Light vaccine was developed for people who have already had a new coronavirus infection or received two doses of the two-component Sputnik V vaccine.He noted that the vaccine can also be used for primary vaccination of certain categories of the population.For people over 60 years old, Sputnik Light cannot be used, Murashko added.
Doctor of Biological Sciences Alexander Alekseevich Chepurnov noted that Sputnik Light is suitable forand for primary vaccination "out of necessity".The same idea was confirmed by the doctorAnatoly Davidovich Alshtein added that Sputnik Light is similar in function and operation to the first component of the Sputnik V vaccine, after which in about 3-4 weeks there areAntibodies.
The vaccine also has contraindications, for example,hypersensitivity to any of the components, a history of severe allergic reactions, acute infectious and non-infectious diseases (vaccination is carried out 2-4 weeks after recovery or remission), you cannot yet vaccinate for mild ARVI, acute infectious diseases of the gastrointestinal tract (vaccination is carried out after when the temperature becomes normal), as well as pregnancy, breastfeeding or age under 18 years.
Vaccinations are also recommended with caution.patients with endocrine diseases, chronic liver and kidney disease or the hematopoietic system, also with epilepsy or other problems with the central nervous system and if a person has acute coronary syndrome, acute cerebrovascular accident, myocarditis, endocarditis, pericarditis. And also for patients with autoimmune diseases and malignant neoplasms.
Where can Sputnik Light be implanted?
At the end of July 2021 it became known thatOne third of Russian regions received the vaccine: Sputnik Light was delivered to 35 constituent entities of the Russian Federation, excluding Moscow and the Moscow region. The list of regions where large deliveries reached were: Krasnodar Territory, Dagestan and Tatarstan, Rostov, Chelyabinsk, Sverdlovsk, Leningrad, Irkutsk and Nizhny Novgorod Regions. 10-18 thousand doses were sent there.
But at the end of October it turned out that in the regionsThe demand for the vaccine increased significantly and there was a shortage of Sputnik Light. It was recorded in the Voronezh region, Kurgan, Vologda region, Krasnoyarsk region and St. Petersburg. This interest in Sputnik Light is due to the fact that the vaccine is single-component and immediately after vaccination you can receive a QR code allowing you to visit public places.
An unofficial website has appeared on the Internet, which publishes a map of places where you can get vaccinated with Sputnik Light.
What are the reviews about the Sputnik Light vaccine?
According to research and information fromself-observation diaries, side effects are usually mild or moderate. They occur in the first two days after the vaccine is administered and end within the next three days.
Most often, patients reported influenza-like illnesssyndrome with chills, fever, pain in joints, muscles, general malaise and headache, as well as pain at the injection site and swelling.
Vaccinated people are recommended to take painkillers, antipyretic and anti-inflammatory drugs with an increase in temperature and a pronounced local reaction.
Following the publication of a study in The Lancetvaccine "Sputnik Light", the safety of the drug is more likely to be confirmed. Note that an error can happen in scientific research at any level, but a reputable international journal is one of the most reliable guarantees.
Despite this, mass vaccination may be less successful if the pace of production and delivery of Sputnik Light is reduced. Especially during the period of increasing restrictions in the regions.
Read more:
A huge "black hole" was found in the middle of the Pacific Ocean. The network is wondering what it is
Large reserves of organic matter were again discovered on Mars. Scientists are looking for traces of life
Divers have found the treasures of the legendary "Island of Gold". Artifacts cost millions of dollars